AstraZeneca's inhaler for lung disease shows improved...
Jan 26 (Reuters) - AstraZeneca said its inhaler for chronic obstructive pulmonary disease (COPD) showed improved lung function in a late stage trial that...
from Articles | Mail Online
from Articles | Mail Online
No comments